ada guidelines dpp4 and glp-1 Prescribing pearls: A guide to DPP-4 inhibitors (gliptins) SGLT2 inhibitors-what do guidelines say?

PubMed pubmed.ncbi.nlm.nih.gov [46] GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity PubMed pubmed.ncbi.nlm.nih.gov [47] Semaglutide for the treatment of obesity PubMed pubmed.ncbi.nlm.nih.gov [48] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [49] GLP-1 Receptor Agonists for Treatment of Pediatric Obesity: Behavioral Health Considerations PubMed pubmed.ncbi.nlm.nih.gov [50] Role of GLP-1 Receptor Agonists in Pediatric Obesity: Benefits, Risks, and Approaches to Patient Selection PubMed pubmed.ncbi.nlm.nih.gov [51] Adverse Effects of GLP-1 Receptor Agonists PubMed pubmed.ncbi.nlm.nih.gov [52] Use of glucagon-like-peptide 1 receptor agonist in the treatment of childhood obesity PubMed pubmed.ncbi.nlm.nih.gov [53] A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point

M., Alam, U

doi: 10.1016/j.jceh.2012.12.001 24 RestrepoB

Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

Effect of vitamin D status on clinical pregnancy rates following in vitro fertilization